Among four cohorts (GSE6532-GPL570, GSE1379, GSE3494-GPL97, GSE4922-GPL97) including different stages of breast cancer, high NTN4 expression was associated with favorable prognosis (Table 2). Here, NTN4 is linked to breast carcinoma.